Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 240-986-1 | CAS number: 16924-00-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
In vitro Gene Mutation Study in Bacteria
In a GLP bacterial reverse mutation assay conducted in accordance with standardised guidelines OECD 471, EU Method B.13/14 and EPA OPPTS 870.5100, the genotoxicity of the test substance was determined. Four strains of S. typhimurium and one strain of E. coli were treated in the absence and presence of metabolic activation. Under the conditions of the test, no evidence of mutagenic activity in the bacterial system was observed and the test material was determined to be negative for genotoxicity.
In vitro Chromosome Aberration
The genotoxicity of the test material was investigated in a GLP study which was conducted in accordance with standardised guidelines OECD 473, EU Method B.10 and EPA OPPTS 870.5375 using Chinese hamster V79 lung cells. The study included two rangefinding cytotoxicity assays and three chomosome aberration assays. As the test material did not show repeatable induction of chromosome aberrations it was considered to be negative in this test.
In vitro Gene Mutation in Mammalian Cells
Dipotassium Heptafluorotantalate was evaluated for its ability to induce thymidine kinase gene mutations using the in vitro mammalian mouse lymphoma assay (MLA). The test laboratory indicated that the study was performed according to OECD Test Guideline TG476 (1997) and using Good Laboratory Practices. The acceptance criteria and the test interpretation criteria were indicated to be based on those of Moore et al, 2006; these criteria result from an international harmonization effort of the Mouse Lymphoma Expert Workgroup of the International Workshop for Genotoxicity Tests (IWGT). The test laboratory conducted several experiments and presented data for (1) two experiments with a 3 hour treatment with metabolic activation, (2) one experiment for a 3 hour treatment without metabolic activation, (3) and one experiment for a 24 hour treatment without metabolic activation.
The test laboratory concluded that Dipotassium Heptafluorotantalate was mutagenic with metabolic activation and not mutagenic in the absence of metabolic activation.
There are, however, multiple issues that cast serious doubt on the positive results. These issues are summarized in the attached report (Comments on MLA for dipotassium heptafluorotantalate_final.pdf). It is recommended that the MLA study with Dipotassium Heptafluorotantalate be repeated to correct the deficiencies and to provide an appropriate evaluation as to whether it is actually mutagenic. This repeat study will be conducted with and without metabolic activation within 6 month after ECHAs draft decision on conducting an in vivo test was rejected (TPE-D-2114305085-61-01/D).
Justification for selection of genetic toxicity endpoint
As multiple studies are presented to address genetic toxicity, no one study was selected as the key study as they represent different types of genetic toxicity and are therefore not comparable.
Short description of key information:
In vitro Gene Mutation Study in Bacteria
Negative (with and without metabolic activation), OECD 471, EU Method B.13/B.14, EPA OPPTS 870.5100, Kitching (2001)
In vitro Chromosome Aberration
Negative (with and without metabolic activation), OECD 473, EU Method B.10, EPA OPPTS 870.5375, Hargitai (2013)
In vitro Gene Mutation in Mammalian Cells
Negative (without metabolic activation); Positive (with metabolic activation), OECD 476, EU Method B.17, Hargitai (2013)
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
In accordance with with criteria for classification and labelling as defined in Regulation (EC) No 1272/2008 (CLP) and Directive 67/548/EEC (DSD), the substance does not require classification for genetic toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.